Hogan SL - Search Results

1

Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.

Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL, Frye RF, Blaisdell J, Goldstein JA, Dooley MA, Brouwer KL, Falk RJ. Joy MS, et al. Among authors: hogan sl. Br J Clin Pharmacol. 2012 Sep;74(3):445-55. doi: 10.1111/j.1365-2125.2012.04223.x. Br J Clin Pharmacol. 2012. PMID: 22380717 Free PMC article. Clinical Trial.

2

Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.

Falk RJ, Hogan SL, Muller KE, Jennette JC. Falk RJ, et al. Among authors: hogan sl. Ann Intern Med. 1992 Mar 15;116(6):438-45. doi: 10.7326/0003-4819-116-6-438. Ann Intern Med. 1992. PMID: 1371211 Clinical Trial.

3

Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA).

Falk RJ, Hogan SL, Wilkman AS, Terrell RS, Lauritzen S, Charles LA, Jennette JC. Falk RJ, et al. Among authors: hogan sl. Neth J Med. 1990 Apr;36(3-4):121-5. Neth J Med. 1990. PMID: 2162486 No abstract available.

4

Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Falk RJ, Hogan S, Carey TS, Jennette JC. Falk RJ, et al. Ann Intern Med. 1990 Nov 1;113(9):656-63. doi: 10.7326/0003-4819-113-9-656. Ann Intern Med. 1990. PMID: 2221646

5

A review of therapeutic studies of idiopathic membranous glomerulopathy.

Hogan SL, Muller KE, Jennette JC, Falk RJ. Hogan SL, et al. Am J Kidney Dis. 1995 Jun;25(6):862-75. doi: 10.1016/0272-6386(95)90568-5. Am J Kidney Dis. 1995. PMID: 7771482

6

Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.

Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Detwiler RK, et al. Among authors: hogan sl. Kidney Int. 1994 May;45(5):1416-24. doi: 10.1038/ki.1994.185. Kidney Int. 1994. PMID: 8072254 Free article.

7

Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Hogan SL, et al. J Am Soc Nephrol. 1996 Jan;7(1):23-32. doi: 10.1681/ASN.V7123. J Am Soc Nephrol. 1996. PMID: 8808106

8

Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Nachman PH, Hogan SL, Jennette JC, Falk RJ. Nachman PH, et al. Among authors: hogan sl. J Am Soc Nephrol. 1996 Jan;7(1):33-9. doi: 10.1681/ASN.V7133. J Am Soc Nephrol. 1996. PMID: 8808107 Clinical Trial.

9

A renal biopsy in essential for the management of ANCA-positive patients with glomerulonephritis.

Falk RJ, Moore DT, Hogan SL, Jennette JC. Falk RJ, et al. Among authors: hogan sl. Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):230-1. Sarcoidosis Vasc Diffuse Lung Dis. 1996. PMID: 8946588 Review. No abstract available.

10

Comparison of measures for prospective identification of venous stenoses.

Dinwiddie LC, Frauman AC, Jaques PF, Mauro MA, Hogan SL, Falk RJ. Dinwiddie LC, et al. Among authors: hogan sl. ANNA J. 1996 Dec;23(6):593-600. ANNA J. 1996. PMID: 9069788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page